Search results for "Santé publique et épidémiologie"

showing 10 items of 258 documents

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

2021

ObjectiveThe benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA administration.DesignWe pooled the data of 977 consecutive patients from 21 studies of HCV-related cirrhosis and HCC, who achieved complete radiological response after surgical/locoregional treatments and received DAAs (DAA group). Recurrence or death risk was expressed as HCC recurrence or death per 100 person-years (100PY). Propensity score-matched patients from the ITA.LI.CA. cohort (n=328) served as DAA-unexposed controls (no-DAA group). Risk fac…

medicine.medical_specialtyCarcinoma HepatocellularCirrhosisAntiviral AgentsGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineantiviral therapymedicineHumansPropensity Scoreantiviral therapy; hepatocellular carcinoma; meta-analysisbusiness.industryLiver NeoplasmsGastroenterologyAntiviral therapyPatient datahepatocellular carcinomamedicine.disease3. Good healthmeta-analysis030220 oncology & carcinogenesisMeta-analysisHepatocellular carcinomaRelative riskCohort030211 gastroenterology & hepatology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieNeoplasm Recurrence LocalbusinessDirect acting
researchProduct

Cancer and Infective Endocarditis: Characteristics and Prognostic Impact

2021

Background: The interplay between cancer and IE has become of increasing interest. This study sought to assess the prevalence, baseline characteristics, management, and outcomes of IE cancer patients in the ESC EORP EURO-ENDO registry.Methods: Three thousand and eighty-five patients with IE were identified based on the ESC 2015 criteria. Three hundred and fifty-nine (11.6%) IE cancer patients were compared to 2,726 (88.4%) cancer-free IE patients.Results: In cancer patients, IE was mostly community-acquired (74.8%). The most frequently identified microorganisms were S. aureus (25.4%) and Enterococci (23.8%). The most frequent complications were acute renal failure (25.9%), embolic events (2…

medicine.medical_specialtyCardiovascular Medicineregistryvalve diseasesurgeryInternal medicinemedicinecancerDiseases of the circulatory (Cardiovascular) systemOriginal Researchbusiness.industryinfective endocarditisCancermedicine.diseaseCardiac surgery[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBaseline characteristicsHeart failureInfective endocarditisRC666-701oncologyCohort[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieObservational studyCardiology and Cardiovascular MedicinebusinessValve diseasecardiac surgeryFrontiers in Cardiovascular Medicine
researchProduct

Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France

2020

International audience; The aim of this study was to document the extent to which diabetic patients who adhered to required medical follow‐ups in France experienced reduced hospital admissions over time. The main assumption was that enhanced monitoring and follow‐up of diabetic patients in the primary care setting could be a substitute for hospital use. Using longitudinal claim data of diabetic patients between 2010 and 2015 from MGEN, a leading mutuelle insurance company in France, we estimated a dynamic logit model with lagged measures of the quality of adherence to eight medical follow‐up recommendations. This model allowed us to disentangle follow‐up care in hospitals from other forms o…

medicine.medical_specialtyLogistic regression03 medical and health sciences0302 clinical medicineDiabetes mellitusDiabetes MellitusmedicineHumansIn patient030212 general & internal medicineHealth policyHospital useDiabetic patientsHospital admissionsInpatient carebusiness.industry030503 health policy & servicesHealth PolicyPublic healthmedicine.disease[SHS.ECO]Humanities and Social Sciences/Economics and FinanceHospitals3. Good healthHospitalizationEmergency medicine[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFrance0305 other medical sciencebusinessFollow-Up StudiesPanel data
researchProduct

The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations.

2011

 ; International audience; The LCOT is a self-administered test designed to assess olfactory deficits. Altogether, 525 subjects contributed to the validation. Elderly participants were well represented in this sample. In a validation study (study 1), 407 healthy and 17 anosmic volunteers between 15 and 91 years of age underwent threshold, supraliminal detection, and identification testing. Cutoff values for normosmia and hyposmia were calculated and applied in a second study in a group of patients with smell complaints and in a group of Alzheimer patients with age-matched controls. Incidence of smell deficit was estimated at 5.6% in the healthy population of study 1, and at 16% in the elder…

medicine.medical_specialtyValidation studyArticle SubjectOlfactory disorderAnosmialcsh:SurgeryMédecine humaine et pathologieOlfactionTest validityAudiologyBioinformaticsaging;development;olfaction;olfactory disorder;Alzheimer's disease;cognitive impairment03 medical and health sciences0302 clinical medicineHyposmiamedicineFood and Nutrition[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs030223 otorhinolaryngologyolfactory disorderdevelopmentcognitive impairmentbusiness.industryIncidence (epidemiology)Healthy populationaging[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologielcsh:RD1-811Alzheimer's diseaselcsh:Otorhinolaryngologylcsh:RF1-547[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansAlimentation et NutritionNeurosciences (Sciences cognitives)Human health and pathology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusiness030217 neurology & neurosurgeryResearch ArticleNeuroscienceolfaction
researchProduct

Psychosocial factors burden in workers with acute cerebro- or cardiovascular events: A multidisciplinary prospective pilot study

2018

Introduction Psychosocial stress at work has been proposed as a risk factor for cerebro- and cardiovascular event (CVE) such as stroke or acute myocardial infarction (MI). However, data on psychosocial factors (PSF) profile in patients with CVE are scarce. In a multidisciplinary approach, we aimed to characterize PSF burden in patients with acute stroke or MI. Patients In a prospective pilot study, 45 patients aged  Results Among the 44 patients included, 77% had acute MI and 23% stroke. Mean age was 50 years, 77% were male, 43% were current smokers, 39% had hypertension, 41% hypercholesterolemia and 36% obesity. Education level was at 4,65 (secondary education), and most (41%) had low soci…

medicine.medical_specialty[SHS.PSY]Humanities and Social Sciences/PsychologyDisease030204 cardiovascular system & hematology[SHS.PSY] Humanities and Social Sciences/Psychology03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemQuality of lifeInternal medicinemedicinecardiovascular diseases030212 general & internal medicineMyocardial infarctionRisk factorStrokeComputingMilieux_MISCELLANEOUSDepression (differential diagnoses)business.industrymedicine.disease3. Good healthAnxiety[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptomCardiology and Cardiovascular MedicinebusinessPsychosocialArchives of Cardiovascular Diseases Supplements
researchProduct

Oral health and adherence to national dietary guidelines in France

2017

International audience

medicine.medical_specialtyconsumer behaviorOral healtheating behaviordentition03 medical and health sciences0302 clinical medicineNursingMedicineNUTRINET030212 general & internal medicinetoothComputingMilieux_MISCELLANEOUSteethbusiness.industryGOHAI030503 health policy & servicesPublic Health Environmental and Occupational Healthcohort[SDV.AEN] Life Sciences [q-bio]/Food and NutritionnutritionageFamily medicineoral healthdietary[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePNNS0305 other medical sciencebusinessdiet[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute in…

2013

Abstract In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To ans…

medicine.medical_specialtymedicine.drug_class[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AntibioticsMEDLINEContext (language use)ReviewCritical Care and Intensive Care MedicineProcalcitoninC-reactive proteinsuPARsepsis03 medical and health sciences0302 clinical medicineAntibiotic resistanceemergency medicineAntibiotic therapy[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Medicine030212 general & internal medicineIntensive care medicine030304 developmental biologyddc:6160303 health sciencessepticemie[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryPresepsin[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieproADMsTREM-1infection3. Good healthSanté publique et épidémiologie[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBiomarker (medicine)infection;sepsis;emergency medicine;biomarker;procalcitonin;C-reactive protein;sTREM-1;suPAR;proADM;resepsinbiomarker[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieresepsinbusinessbiomarqueurBiomarkersprocalcitonin
researchProduct

The EHA research roadmap

2021

International audience; In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research(1) aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published…

medicine.medical_specialtymedicine.medical_treatmentPlatelet disorderClinical scienceHematopoietic stem cell transplantation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicinemedicineDiseases of the blood and blood-forming organsIntensive care medicine030304 developmental biology0303 health sciencesHematologybusiness.industryTransfusion medicineHematologyHemostatic Disorders3. Good healthBlood DisorderEuropean policy[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologiePerspective[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRC633-647.5businessHemaSphere
researchProduct

The impact of COVID-19 on access to dental care for people with disabilities:a global survey during the COVID-19 first wave lockdown

2021

Background It is unclear what immediate impact the COVID-19 pandemic has had on delivery of oral healthcare to people with disabilities worldwide. Aim: To report the international impact of COVID-19 lockdown on oral healthcare provision for people with disabilities before, during and after the first lockdown (March to July 2020). Material and Methods Cross-sectional online self-administered survey of dentists who treat people with disabilities completed 10th to 31st of July 2020. Responses allowed comparison from before, during and immediately after the first wave lockdowns of the COVID-19 pandemic. Data were analysed using McNemar’s test to compare reported practice before to during lockdo…

medicine.medical_specialtyoral mucosal lesionsCoronavirus disease 2019 (COVID-19)prevalenceMEDLINE03 medical and health sciencesaccess0302 clinical medicineMcNemar's testSurveys and QuestionnairesHealth carePandemicoral potentially malignant disordersMedicineHumansGeneral anaesthesiaDisabled Persons030212 general & internal medicineTeledentistryDental CareGeneral DentistryPandemicsUNESCO:CIENCIAS MÉDICASbusiness.industrySARS-CoV-2ResearchCOVID-19oral cancerMedically compromised patients in Dentistry3. Good healthTest (assessment)Cross-Sectional StudiesdisabilityOtorhinolaryngologyFamily medicineCommunicable Disease Control[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSurgerybusiness030217 neurology & neurosurgery
researchProduct

Treatment-resistant depression in a real-world setting: first interim analysis of characteristics, healthcare resource use, and utility values of the…

2020

Background: Major depressive disorder (MDD) is among the most common psychiatric disorders. One-third of patients are usually unresponsive to several lines of treatment. This study aimed to describe the FondaMental French cohort of patients with treatment-resistant depression (TRD) and to estimate utility and healthcare resource use outcomes. Methods: Patients with TRD were evaluated prospectively over four years (baseline, 6, 12, 18, 24, 36 and 48 months) in a real-world clinical setting. Interim analyses focused on the first two consecutive years. Four MDD-related states (major depressive episode (MDE), response, remission, recovery) were defined based on the MADRS (Montgomery&ndash

medicine.medical_specialtyreal-world[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthArticlelcsh:RC321-57103 medical and health sciences0302 clinical medicinehealthcare resource useQuality of lifeRating scaleInternal medicineMedicine[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Major depressive episodelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryDepression (differential diagnoses)business.industryGeneral Neurosciencemedicine.diseaseInterim analysis3. Good health030227 psychiatryutility[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthCohorttreatment-resistant depressionMajor depressive disorder[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessTreatment-resistant depression030217 neurology & neurosurgery
researchProduct